IGM Biosciences, Inc. (IGMS) Net Income (Loss) Attributable to Parent USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
IGM Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to 2024.
  • IGM Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$49.8 M, a 16% increase year-over-year.
  • IGM Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$237 M, a 3.68% decline year-over-year.
  • IGM Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$246 M, a 11.4% decline from 2022.
  • IGM Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$221 M, a 33.9% decline from 2021.
  • IGM Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$165 M, a 103% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$237 M -$49.8 M +$9.49 M +16% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$246 M -$60.7 M -$8.12 M -15.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$238 M -$62 M -$3.95 M -6.81% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$234 M -$64.4 M -$5.83 M -9.95% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-13
Q1 2023 -$229 M -$59.3 M -$7.42 M -14.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$221 M -$52.6 M -$1.93 M -3.82% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$219 M -$58 M -$13.9 M -31.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$205 M -$58.6 M -$19.9 M -51.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$185 M -$51.9 M -$20.3 M -64% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$165 M -$50.6 M -$26 M -106% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-07
Q3 2021 -$139 M -$44.2 M -$23.9 M -118% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$115 M -$38.7 M -$19.9 M -105% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$95.4 M -$31.6 M -$14 M -79.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$81.4 M -$24.6 M -$9.81 M -66.2% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-30
Q3 2020 -$71.5 M -$20.3 M -$10.1 M -99.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$61.5 M -$18.8 M -$8.16 M -76.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$53.3 M -$17.6 M -$10.2 M -136% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 -$43.1 M -$14.8 M -$5.76 M -63.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$37.4 M -$10.2 M -$3.66 M -56.1% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-30
Q2 2019 -$33.7 M -$10.7 M -$6.46 M -153% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-30
Q1 2019 -$27.3 M -$7.47 M -$4.54 M -155% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-30
Q4 2018 -$22.7 M -$9.05 M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 -$6.52 M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-26
Q2 2018 -$4.22 M Apr 1, 2018 Jun 30, 2018 10-K 2020-03-26
Q1 2018 -$2.93 M Jan 1, 2018 Mar 31, 2018 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.